Synopsis of recent research by authors named "Hahn Sun Jung"
Recent research by Hahn Sun Jung focuses primarily on the development and characterization of recombinant proteins for therapeutic applications, specifically in the fields of immunology and cancer treatment.
Key findings include the successful production of immunosuppressive agents, such as hCTLA4Ig, in transgenic rice cell cultures, which exhibited comparable in vitro efficacy to traditionally produced proteins while addressing issues related to immunogenicity.
Additionally, studies on antibodies against autocrine motility factor (AMF) demonstrated their potential to inhibit gastric cancer growth, highlighting the therapeutic significance of targeting specific tumor-promoting factors. *
